Pharma's bad boy: Livestreaming, rap-fan CEO faces charges
By Associated Press JENNIFER PELTZ
•
21 December 2015, 12:00AM
NEW YORK (AP) — He's the enfant terrible of pharmaceuticals, a 32-year-old CEO who unapologetically raised the price of the only approved drug for a rare disease from $13.50 to $750 per pill.
He's a millionaire music aficionado who riled rap fa
By Associated Press JENNIFER PELTZ
•
21 December 2015, 12:00AM